Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

详细信息	查看全文 | 推荐本文 |

• 作者：Marianne Nordsmark ; Sø ; ren M. Bentzen ; Volker Rudat ; David Brizel ; Eric Lartigau ; Peter Stadler ; Axel Becker ; Markus Adam ; Michael Molls ; Juergen Dunst et al.
• 刊名：Radiotherapy and Oncology
• 出版年：2005
• 期刊代码：231_01678140
• 类别：med
• 出版时间：2005
• 卷：77
• 期：1
• 页码：18-24
• 文件大小：137 K

摘要

Purpose

To analyze the relationship between pre-treatment measurements of tumor oxygen tension (pO₂) and survival in advanced head and neck cancer.

Patients and methods

Eppendorf pO₂ measurements in 397 patients from seven centers were analyzed using the fraction of pO₂ values ≤2.5 mmHg (HP_2.5), ≤5 mmHg (HP₅) and median tumor pO₂ (mmHg) as descriptors. All patients had intended curative radiation therapy alone or as pre- or post-operative radiotherapy or radio-chemotherapy according to the practice at each center.

Results

The degree of hypoxia varied between tumors with an overall median tumor pO₂=9 mmHg (range 0–62 mmHg), a median HP_2.5=19%(range 0–97%) and HP₅=38%, (range 0–100%). By quadratic regression median tumor pO₂ correlated with Hb (2P=0.026, n=357), while HP_2.5 or HP₅ did not. HP_2.5 above the population median was the only parameter that associated with poor overall survival (Kaplan Meier analysis, P=0.006). In a multivariate Cox Proportional Hazards analysis, stratified according to institution HP_2.5 was by far the most statistically significant factor in explaining the variability in survival. After adjusting for HP_2.5, clinical stage, radiation dose and surgery hemoglobin concentration was not significant in the model. The prognostic model shows that the 5-year survival is almost constant for HP_2.5 values in the range from 0 to 20%, whereas the 5-year survival approaches 0%in the most hypoxic tumors.

Conclusion

This study provides evidence that tumor hypoxia is associated with a poor prognosis in patients with advanced head and neck cancer.